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Chapter 1
Introduction
1.1

Purpose of Study

Even with advances in cancer research and technology cancer is the second leading cause
of death in the United States as no cure exists1. According to the latest America Cancer
Society statistics2, this year alone nearly 560,000 people will die from the disease. Of the
total 1.45 million that will be diagnosed, 218,000 will be prostate carcinoma and over
27,000 cases will result in death2. There is, however, a strong connection between early
detection and positive patient outlook. In the case of lung cancer there is a 70% survival
rate for resected infected tissue in stage I carcinoma versus only 12% when the cancer is
not detected in this stage3. Besides lung carcinoma, early detection is the best hope in all
cancers, to improve patient survival, disease prognosis and may lead to cancer
prevention.

The major goal of this research is to develop a rapid, ultrasensitive, economic, and
specific nanomaterial-based sensor for the early detection of cancer biomarker proteins,
particularly Prostate Specific Antigen (PSA), in clinically relevant samples, such as
serum and tissue lysate. In this research study, we are using vertically aligned singlewalled carbon nanotubes (SWNT) attached to conductive surfaces capable of electrical
conduction to fabricate these ultrasensitive sandwich immuosensors. The electrical signal

1

Ahmedin Jemal, Taylor Murray, Elizabeth Ward, Alicia Samuels, Ram C. Tiwari, Asma Ghafoor, Eric J.
Feuer, Michael J. Thun. CA Cancer J. Clin. 2005, 55(1), 10-30.
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Estimated New Cancer Cases and Deaths by Sex for All Sites, US, 2007. American Cancer Society.
2007. 15 Apr. 2007 <http://www.cancer.org/downloads/stt/CFF2007EstCsDths07.pdf>.
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Henschke, Claudia; Dorthy I. McCauley, David F. Yankelevitz, David P Naidich, Gergeann McGuiness,
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Smith. The Lance. 1999, 354, 99-105.
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is realized using enzyme catalytic reactions involving Horseradish Peroxidase (HRP)
tracer in the antibody-antigen biorecognition event.

This project employs SWNT with ~1.4 nm diameters and the world’s highest
conductivity per unit mass4. We have combined efficient electrical transduction by
shortened carbon nanotubes with biomolecular recognition by antibodies. Electronic
devices offer elegant ways for interfacing biorecognition and transduction events and are
uniquely qualified for meeting the high sensitivity and portability requirements of future
biodetection systems5,6. Electrochemical bioassays involving enzyme tracers have
received particular attention due to the intrinsic signal amplification provided by
biocatalytic reactions.

An important future goal of this project is to develop a protein sensor array that is capable
of measuring a collection of cancer biomarker proteins in a single sample. This array
would allow for lower cost per analysis and a clinically viable approach for early cancer
detection. The onset of cancer is indicated by biomarker serum level change over time7.
These biomarkers often indicate at abnormal levels, or abnormal level changes over time,
a disturbance in the proper regulation of a specific tissue or organ often indicating
carcinoma8.

4

Dresselhaus, M. S.; Dresselhaus, G.; Avouris, P.; Editors, Carbon nanotubes: Synthesis, Structure,
Properties, and Applications. Topics Appl. Phys., 2001.
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Palecek, E.; Fojta, M. Detecting DNA hybridization and damage. Anal. Chem. 2001, 73, 75A.
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Wang, J. Real-time electrochemical monitoring: toward green analytical chemistry. Acc. ChemRes.2002,
35, 811.
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of California Los Angeles Medical School. 23 Mar. 2007
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Currently there are many methods for detection of proteins, however all have many
drawbacks.

DNA microarrays measure gene expression by quantifying messenger RNA

levels. However, these mRNA levels are not indicative of protein expression8. Protein
microarrays, specifically ELISA, are another similar method where antibodies and
enzyme-labeled secondary antibodies are used in a sandwich immunoassay. This method
is selective and sensitive but is limited by the required sample size and time9.

Mass spectrometry (MS) is yet another method for protein detection. This technique
requires liquid chromatograph protein purification, proteolytic cleavage of peptide chains
and labeling with isotopes for analysis, which is labor-intensive and expensive10. This is
an unlikely method for mass sampling in a timely and reasonably priced manner.

This innovative immunosensor design would lead to a miniaturized electrochemical
immunosensor arrays with higher throughput and lower cost per analysis. Such a device
would be a clinically viable approach for early cancer detection compared to expensive
and complex MS methods. We believe that the SWNT protein microarrays offer
unprecedented promise for early cancer diagnosis.

Chapter 2 of this thesis describes peroxidase activity of horseradish peroxidase and
myoglobin on vertically aligned carbon nanotubes; key steps in the electrochemical
detection scheme. These initial studies were intended to establish the optimum conditions
for the SWNT “forest” fabrication and also serve as quality control experiments to

9
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determine the quality of our SWNT forests. Electrode-driven peroxidase activity of
myoglobin and horseradish peroxidase attached to the carbon nanotube arrays was
demonstrated, with detection limits for hydrogen peroxide in buffer solutions of ~100
nM. Our results suggest that the vertically aligned nanotube arrays behave like metal
electrical conductors shuttling electrons from the external circuit to redox active sites of
the enzymes.

Chapter 3 demonstrates our novel nanomaterial-based sensor for use in electrochemical
detection of prostate specific antigen. We obtained a detection limit of 0.4 ng/mL, which
compares favorably with common methods such as enzyme-linked immunosorbent assay
(ELISA). Work is currently in progress to lower the detection limits using signal
amplification strategies, the established optimized SWNT array fabrication protocol and
conditions for minimal non-specific binding events.

Finally, chapter 4 addresses the Pell honors program connection with this research work.
As a Pell student, with the goal of learning to understand the importance of international
relations and public policy, I have found through this research experience that early
detection of cancer biomarkers is a key step towards improving cancer patient’s survival
and may even lead to cancer prevention. Increasing the sensitivity of the detection
methods would indicate this early detection and therefore would be essential in lowering
healthcare costs for cancer patients as treatments would be much less invasive and time
consuming. Detection of high levels of PSA in serum can lead to detection of prostate
cancer well before surgery is required, resulting in much less aggressive, more successful
treatments that minimize patient discomfort and physiological dysfunction.
10

1.2

Prostate Specific Antigen

PSA is a single chain glycoprotein from the Kallikrein family of proteolyses11. It is
composed of a 237 amino acid chain having a molecular weight of 26kDa12. PSA has
multiple epitopes capable of binding with monoclonal antibodies, which in this research
is essential to its detection13. PSA is a known biomarker for the detection of prostate
cancer8. The detection of PSA rising levels allows for a probable diagnosis of prostate
cancer.

1.3

Carbon nanotubes

Single-Wall carbon nanotubes (SWNTs) are essentially a seamless cylinder of graphene.
The tubes are capable of acting as conductors or semiconductors depending on the chiral
alignment of the molecules. These one-dimensional fibers exhibit electrical conductivity
as high as copper, thermal conductivity as high as diamond, strength 100 times greater
than steel at one sixth the weight, and high strain to failure (high aspect ratio)14. There are
two types of carbon nanotubes, SWNT and multi-wall carbon nanotubes (MWNT).
MWNT possess the properties of the SWNTs but are composed of one graphene cylinder
inside of another.

The SWNTs used in this experiment are capable of single electron conduction. At 1.4nm
diameter SWNTs have the highest conductivity per unit mass in the world. The SWNT
11

RCSB Protein Data Bank. wwwPDB. 15 Apr. 2007
<http://www.rcsb.org/pdb/explore.do?structureId=1GVZ>.
12
Belanger, A; H Van Halbeek; HC Graves; K Grandbois; Ta Stamey; L Huang; I Poppe; and F Labrie.
Prostate 1995, 27, 187-197
13
Leinonen, J.; Wu, P.; Stenman, U. Clinical Chemistry. 2002, 48, 2208-2216.
14
"Nanotubes and Buckyballs." Nanotechnology Now. 15 Aug. 2006. 7 Mar. 2007 <http://www.nanotechnow.com/nanotube-buckyball-sites.htm>.
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used in this work are carboxyl functionalized by acid treatment and are capable of
attachment of biological molecules by bioconjugation reactions. Due to their unique
structural, electronic, thermal, and mechanical properties they have found wide

Figure 1-1.Prostate Specific Antigen structure as determined by x-ray diffraction15.

15

RCSB Protein Data Bank. wwwPDB. 15 Apr. 2007
<http://www.rcsb.org/pdb/explore.do?structureId=1GVZ>.

12

Figure 1-2. Two type of carbon nanotubes, SWNT and MWNT
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applications in various bioanalytical applications including electrochemical detection by
cyclic voltammetry and amperometry.
1.4

Horseradish Peroxidase

Horseradish peroxidase (HRP) is a member of the ferroprotoporphyrin group of
peroxidases. It is a single chain polypeptide containing a central heme group. This heme
group is capable of catalytic oxidation reduction by hydrogen peroxide16. Peroxidases
have

been

used

extensively

for

sensitive

electrochemical

detection

in

immunosensing17,18,19 and DNA hybridization5,20,21. They are excellent labels for
electrochemical immunoassays since highly active peroxidases give large catalytic
electrochemical signals for reduction of hydrogen peroxide at low applied voltages where
little interferences is expected22,23.

16

"Peroxidase Enzymes and Reagents." Enzyme Explorer. 2007. Sigma-Aldrich. 15 Apr. 2007
<http://www.sigmaaldrich.com/Area_of_Interest/Biochemicals/Enzyme_Explorer/Analytical_Enzymes/Per
oxidase_Enzymes.html>.
17
Lu, B.; Iwuoha, E. I.; Smyth, M. R.; O’Kennedy, R. Development of an amperometric immunosensor for
horseradish peroxidase (HRP) involving an non-diffusional osmium redox polymer co-immobilized with
anti-HRP antibody, Anal. Commun. 1997, 34, 21-23.
18
Killard, A. J.; Zhang, S.; Zhao, H.; John, R.; Iwuoha, E. I.; Smyth, M. R. Anal. Chim. Acta 1999, 400,
109-119.
19
Killard, A. J.; Micheli, L.; Grennan, K.; Franek, M.; Kolar, V.; Moscone, D.; Palchetti, I.;
Smyth, M. R. Anal. Chim. Acta 2001, 427, 173-180.
20
Azek, F.; Grossiord, C.; Joannes, M.; Limoges, B.; Brossier, P. Anal. Biochem. 2000, 284, 107-113.
21
Caruana, D. J.; Heller, A. J. Am. Chem. Soc. 1999, 121, 769-774.
22
Ruzgas, T.; Lindgren, A.; Gorton, L.; Hecht, H.-J.; Reichelt, J.; Bilitewski, U. in Chambers, J. Q. and
Bratjer-Toth, A. Eds. Electroanalytical Methods for Biological Materials, Marcel Dekker, New York,
2002, pp. 233-254.
23
Guo, Y.; Guadalupe, A. R. Direct electrochemistry of horseradish peroxidase adsorbed on glassy carbon
electrode from organic solutions. Chem. Comm. 1997, 1437-1438.
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Figure 1-3. Heme group of Horseradish Peroxidase24.

24

Prahl, Scott. “Structure of Heme.” 8 June 1998. Oregon Medical Laser Center. 20 April 2007.
<http://omlc.ogi.edu/spectra/hemoglobin/hemestruct/index.html>.

15

Chapter 2
Peroxidase Activity of Horseradish Peroxidase and Myoglobin
on Vertically Aligned Carbon Nanotubes
2.1. Abstract
2.2.

Introduction

Arrays of highly conducting single-wall carbon nanotubes (SWNTs) could be uniquely
suited for bioanalytical applications by coupling sensing biomolecules to the carboxylterminated ends25,26 of the nanotubes. There are a number of established methods for
assembling 20-100nm vertically aligned carbon nanotube arrays on surfaces in nm-scale
bundles called SWNT forests i.e., dense orthogonally oriented arrays of shortened
SWNTs, onto various solid substrates

27, 28, 29

. In agreement with our first major goal in

this research work to optimize the SWNT forest assembly, and biomolecular
bioconjugation, we herein demonstrate successful fabrication of vertically aligned SWNT
arrays. Furthermore, we show that the untethered ends of these stable SWNT forests can
be linked to electrochemically active heme proteins through traditional bioconjugate
chemistry to give electrochemical signatures of enzyme activity. In this work, we clearly
show that myoglobin and horseradish peroxidase covalently linked to the SWNT forests
exhibit quasi-reversible FeIII/FeII voltammetry and sensitive responses to H2O2. The
unidimensional nature, high conductivity, and structural robustness of carbon nanotubes
25

Liu, Jie; Andrew G. Rinzler, Hongjie Dai, Jason H. Hafner, R. Kelley Bradley, Peter J. Boul, Adrian Lu,
Terry Iverson, Konstantin Shelimov, Chad B. Huffman, Fernando Rodriguez-Macias, Young-Seok
Shon, T. Randall Lee, Daniel T. Colbert, and Richard E. Smalley Science 1998, 280, 1253
26
Hamon, M.A.; H. Hu, P. Bhowmik, S. Niyogi, B. Zhao, M. E. Itkis, R. C. Haddon Chem. Phys. Lett.
2001, 347, 8.
27
D. Chattopadhyay, I. Galeska and F. Papadimitrakopoulos; J Am. Chem. Soc. 2001, 123, 9451.
28
Gooding, J; W. Rahmat, J. Q. Liu, W. R. Yang, D. Losic, S. Orbons, F. J. Mearns, J. G. Shapter, D. B.
Hibbert. J Am. Chem. Soc. 2003, 125, 9006.
29
Patolsky, F.; Y. Weizmann, I. Willner, Chem. Int. Edition
2004, 43, 2113
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promise important future applications for nanosensors. Unique electrochemistry of
soluble molecules and adsorbed proteins on cast flat non-oriented layers of single of
multi-walled carbon nanotubes has been demonstrated30,31. It has been speculated that the
similarity between size scales of enzymes and chemically shortened, nanoscale diameter
SWNTs might promote the likelihood of SWNTs being able to intimately interact and be
within electron tunneling distance of enzyme redox sites32.
2.3.

Experimental Section

Single-wall carbon nanotubes (HiPco, from Tubes@ rice) were carboxyl functionalized
and shortened by sonication in a mixture of 3:1 HNO3 and H2SO4 for 4 h at 70ºC27.
Monolayers of vertically aligned, shortened SWNTs were assembled on ordinary
pyrolytic graphite (PG) electrodes from DMF dispersions onto an underlying composite
bed of Nafion ionomer and Fe3+-precipitated hydroxides, as described previously27.
SWNTs on the Nafion–Fe(OH)3 layer on PG were dried in vacuo for 18 h. Cyclic
voltammetry and amperometry were done as previously described.

Atomic force microscopy (AFM) was done with a Nanoscope IV scanning probe
microscope. Iron heme proteins horse heart myoglobin (Mb, Sigma, >90%) and
horseradish peroxidase (HRP, Sigma, 250–330 unit mg-1) were attached onto the ends of
the SWNTs in the forest by using the water-soluble carbodiimide, (1-(3(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride, EDC), to promote amide
linkages between the carboxyl-terminated nanotubes and the lysine residue of the

30

Campbell, J.K.; Sun, L.; Crooks, R.M. J. Am. Chem. Soc., 1999, 121, 3779.
Salvetat, J.P; AJ Kulik, JM Bonard, G Andrew, D Briggs, T Stockli. J. Adv. Mater. 1999, 11, 54.
32
Baughman, R. Nanotechnology 2002, 13, 559.
31
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proteins. This was done by placing a 20 µL droplet of freshly prepared 24 mM EDC in
water onto the SWNT forest, immediately followed by adding 30 µL of 3 mg mL-1 Mb
or HRP. EDC and protein solutions were mixed carefully using a syringe needle, reacted
for 4 h, then washed extensively with water.

Figure 2-1. Schematics of the fabrication protocol of the vertically aligned SWNT arrays.
End carboxyl group on the SWNT allow protein bioconjugation facilitating electron
shuttle to active protein redox sites.
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2.4.

Results and Discussion

The SWNT forest construction was optimized using Resonance Raman spectroscopy and
Atomic force Microscopy (AFM). The Raman spectra gave high intensity bands
corresponding to graphite- (G-) and defects- (D-) bands respectively. The D-bands
typically observed between 1250 and 1450 cm-1, originate from the first order scattering
by in-plane hetero-atom substituents, grain boundaries, vacancies or the other defects and
by finite size defects33. Raman spectroscopy also shows peaks at 230 cm-1, which is
characteristic of radial breathing mode (RBM) of SWNT in the Nafion/Fe(OH)3/SWNT
assembly. This peak is absent in Nafion/Fe(OH)3 confirming successful assembly of the
SWNT arrays. The pH of the FeCl3 solution was shown to play a key role in the
successful fabrication of the SWNT forest. Raman spectroscopy shows clearly that the
optimum pH =1.7 gave 100% SWNT coverage which may be attributed to the formation
of Fe(OH)3 nanocrystals that acts a precursor for the metal chelation reaction with the
carboxylated ends of the SWNT.

Figure 2-2 shows AFM images of a SWNT forest on smooth silicon. The width of the
main features on the SWNT forest surface is about 20 nm, significantly larger than the
diameter of a single 1 nm diameter SWNT. This is due to the aggregation of SWNT in
the assembly process and the tip-induced broadening artifact of the AFM34. The height of
the SWNTs is ~40-60 nm, in agreement with that reported previously35. Cyclic
voltammograms (CVs) of SWNT forests (Fig. 2(d)) showed an oxidation–reduction peak
33

Dresselhaus, MS, and PC Eklund. Adv. Phys. 2000, 49, 705.
D. Chattopadhyay; S. Lastella; S. Kim; F. Papadimitrakopoulos. J. Am. Chem. Soc. 2002, 124, 223.
35
Diao, Peng; Liu, Zhongfan; Wu, Bin; Nan, Xiaolin; Zhang, Jin; Wei, Zhong. Chem. Phys. Chem. 02/03,
2002, 898.
34
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pair centered at 0.2 V vs. SCE that has been assigned to carboxylate on non-oriented
SWNT films36.
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Figure 2-2. Raman spectra (A) showing characteristic D bands, G band and RBM
band of SWNT assembled on PG electrodes and the influence of Fe(Cl)3 solution pH
during SWNT assembly, and (B) AFM image of the resulting vertically aligned
SWNT arrays on Si wafers at the optimal pH 1.7.

36

Luo, Hongxia; Shi, Zujin; Li, Nanqiang; Gu, Zhennan; Zhuang, Qiankun. Anal. Chem. 2001, 73, 915.
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Addition of 0.1 mM H2O2 to the buffer resulted in an increase in the peak at -0.8 V,
possibly due to the direct reduction of peroxide. Cyclic voltammograms of the protein–
SWNT films in buffers showed oxidation–reduction peak pairs near -0.21 V vs. SCE for
Mb, and -0.25 V for HRP. These potentials are characteristic of the FeIII/FeII redox
couples of Mb and HRP in thin films37. Furthermore, CV peaks of the SWNTs attributed
to carboxylate disappeared from the CVs, suggesting that carboxyl groups on the SWNTs
reacted during protein coupling. Separations between protein reduction and oxidation
peaks were nearly zero. The peak current of the film increased linearly with increasing
scan rate. All these results are typical of quasi-reversible voltammetry of a thin surfaceconfined layer of redox protein38. Electroactive protein surface concentrations were
estimated by integrating the CV reduction peaks at low scan rates (25–75 mV s-1). These
surface concentrations were 0.17 nmol cm-2 for HRP and 0.09 nmol cm-2 for Mb, based
on PG area (0.2 cm2).

Cyclic voltammogram peaks of the enzymes attached onto SWNT forests were stable,
and did not decay during repetitive multiple scans. Electrodes could be stored for
several weeks in buffer at 4º C with only ~20% loss of peak current. This behavior is
consistent with covalent attachment of the proteins to the carboxylate-bearing ends of
the SWNTs. On the other hand, when the enzymes were placed onto SWNT forests
without EDC coupling, CVs persisted for only a few repetitive scans. Additionally,
when Nafion–Fe(OH)3 under-layers on PG were treated with EDC and enzyme, CV
peaks observed for Mb and HRP decreased to background levels within 30 min or
37
38

Zhang, Zhe; Chouchane, Salem; Magliozzo, Richard S.; Rusling, James F. Anal. Chem. 2002, 74, 163.
Rusling, J. F. Electroanalytical Methods for Biological Materials, Marcel Dekker, N.Y. 2002, pp. 195231.
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less, suggesting only transient binding of the positively charged proteins to the
Nafion–Fe(OH)3 under-layer. When Mb or HRP are coupled to an electrode, a
complex catalytic cycle for the reduction of H2O2 is set up that can be detected via
catalytic reduction current37,39.

Fig. 2-3 shows a large catalytic reduction peak when H2O2 was added to buffers
containing the SWNT/enzyme electrodes. Addition of 0.1 mM H2O2 increased the
peak current 5-fold, and the oxidation peak disappeared. The postulated reaction
mechanism, (Fig. 2-4.)37,39, features multiple catalytic cycles and 3 possible
electrochemical reductions. H2O2 converts the FeIII enzyme to a ferryloxy active
oxidant form. This may be reduced directly at the electrode, but also reacts with H2O2
to give oxygen and regenerate FeIII enzyme. Oxygen can react with the FeII enzyme
formed at the electrode to give the FeII-O2 enzyme, which can also be reduced. From
this complex catalytic system, large amperometric signals are generated from HRP
and/or Mb bound to electrodes poised at -0.3 V vs. SCE. There was a linear increase
in catalytic reduction peak with increasing H2O2 concentration from 1 to 30 mM.
Hydrodynamic amperometry provided better sensitivity of the SWNT/enzyme films
for H2O2 (Fig. 2-5(A)).

The sensitivity to the change in the concentration of H2O2 as the slope of the
calibration curve below 10 mM was 0:050 mA/mM for SWNT/HRP, 50% better than

39

Munge, Bernard; Estavillo, Carmelita; Schenkman, John B.; Rusling, James F. Chem. Bio. Chem. 2003,
4, 82.
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the sensitivity of SWNT/Mb at 0:040 mA/mM (Fig. 2-5(B)). This is consistent with
the better peroxidase activity of HRP compared to Mb. The estimated detection limits
towards H2O2 as three times the noise levels were ~70 nM for SWNT/Mb and ~50
nM for SWNT/HRP.

Figure 2-3. Cyclic voltammograms at 0.3 Vs-1 for (A) SWNT/Mb and (B)
SWNT/HRP after injecting 0.1 mM H2O2 (a), SWNT/protein in anaerobic buffer pH
7.0 (b), SWNT control + 0.1 mM H2O2 (c) and SWNT control in anaerobic buffer pH
7.0 (d).

23

Figure 2-4. Catalytic mechanism for the peroxide (H2O2) reduction using HRP and/or
Mb on electrodes resulting in a large amperometric signal.
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Figure 2-5. Catalytic rotating disk amperometry response at –0.3 V vs. SCE and
3000 rpm showing stepwise increase in current after injection of 1 mM H2O2 (A)
of HRP/SWNT and Mb/SWNT, and (B) corresponding calibration curves. Slope
relates to sensitivity. HRP therefore is more sensitive to redox.
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2.5.

Conclusions

In summary, we demonstrated the optimal conditions for fabrication of vertically
aligned SWNT arrays and their application in a biosensor configuration with enzyme
linked to the ends of the nanotubes. The nanotube forest behaves electrically similar
to a metal, conducting electrons from the external circuit to the enzymes. The
preparation of these prototype SWNT-forest biosensors is easy, and enzyme layers
are stable for weeks. The oriented SWNT forests coupled to antibody-antigen
biorecognition events have great potential of being fabricated as ultramicroelectrodes
on the nanometer scale, for ultra-sensitive immunosensor array applications.

Chapter 3
Immunosensing of PSA using vertically aligned single-walled
carbon nanotube forests
3.1

Abstract

3.2.

Introduction

Prostate specific antigen (PSA), a cancer biomarker protein, is produced by normal
prostate cells. It is essential to fertility and dissolution of seminal fluid40. Clinical
research has found the protein as an important serum marker for prostate carcinoma.
While no specific level designates a diagnosis of prostate cancer, PSA serum level
changes over time are the most valuable way of determining if more diagnostic tests are
needed40.

40

Brosman, Stanley A. "Prostate Specific Antigen." EMedicine From WebMD. 15 June 2006. University
of California Los Angeles Medical School. 23 Mar. 2007
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Currently a PSA test with a 4.0ng/mL sensitivity levels predicts cancer 67.5-80% of the
time. Improving sensitivity levels to be able to detect an increase of 0.75ng/mL over a
year to indicate need of biopsy would possibly prevent cancers that are missed 20-30%
of the time40. The most current method of detection comparable to our method is the use
of optimized ELISA (Enzyme-Linked Immunosorbent Assay)41. This method requires
somewhere between 50-150WL of serum which proves to be challenging when sampling
of tissue is necessary.

Our research team following a literature method42 has self-assembled 20-30nm long
terminally carboxylated single-wall carbon nanotubes (SWNT) into forests standing
upright on bundles of nafion-iron oxide decorated conductive surfaces. The SWNT
forests were previously fully characterized using polarized Raman spectroscopy and
atomic force microscopy which confirmed the vertical orientation of the nanotubes in
bundles of 20-100nm diameter at cover of >98% of the underlying solid substrate43.
Efficient, direct electrical communication was achieved between the highly conductive
nanotubes in these forests and peroxidase enzymes bioconjugated to their ends43,44.

In our protocol, primary antibody on the SWNT sensor binds antigen in the sample,
which in turn, binds a peroxidase-labeled antibody (Figure 3-1). Amperometric signals
are developed by adding small amounts of hydrogen peroxide to a solution bathing the

41

Ward, A.M.; Catto, J.W.F.; Hamdy, F.C. Ann. Clin. Biochem. 2001, 38, 633-651.
Xhattopadyhyay, D. et al. J. Am. Chem. Soc. 2001, 123,9451-9452.
43
Yu, Xin.; Kim, Sang Nyon; Papadimitrakopoulous, F.; Rusling, J. F.. Mol. Biosys. 2005, 1, 70-78.
44
Yu, Xin; Chattopadhyay, D.; Galeska, I; Papadimitrakopoulous; F.; Rusling, J.F. Electrochem. Comm.
2003, 5, 408-411.
42
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sensor to active the peroxidase electrochemical cycle and measuring the current for
catalytic peroxide reduction while the sensor is under constant voltage44, 45

In this chapter, we report a novel SWNT immunosensors and applications to the detection
of a cancer biomarker in clinically relevant serum samples. While label-free strategies are
attractive in that they eliminate the need for antibody labeling, herein we pursue a
enzyme label strategy that provides advantages of enhanced sensitivity and selectivity,
the latter by virtue of requiring two specific binding events for detection.6 Decent
sensitivity was achieved by this non-amplified immunosensor utilizing a bioconjugate
with 1 or 2 horseradish peroxidase (HRP) labels. This resulted in a detection limit of 4
ng mL-1 for prostate specific antigen (PSA) in 10 WL undiluted calf serum.

3.3.

Experimental Section

The fabrication of the SWNT forests on graphite tips was discussed in Chapter 2. Primary
antibody was attached with use of 30WL 400mM EDC [1-(3-(dimethylamino)-propyl)-3ethylcarbodiimide hydrochloride] and 100mM NHSS [N-hydroxysulfosuccinimide]
which was washed off after a 10 minute incubation period. The electrodes were then
immediately incubated at 37°C for 3 hours (optimal) with 20WL of 330 ng/mL primary

45

O'Connor, Maire; Kim, Sang Nyon; Killard, Anthony J.; Forster, Robert J.; Smyth, Malcolm R.;
Papadimitrakopoulos, Fotios; Rusling, James F. Analyst 2004, 129, 1176-1180.
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KE

Figure 3-1. Illustration of Sandwich Immunoassay principles for SWNT
Immunosensors. Initial antibody (Ab1) is bioconjugated to the carboxylated ends of
the carbon nanotube forests. (Prostate Specific Antigen) PSA is then attached to
initial antibody. Finally, the HRP labeled secondary antibody (Ab2) is attached to
PSA allowing for its electrochemical detection.
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anti-PSA antibody (Ab1) in a solution of PBS buffer containing 0.05% Tween-20 at a pH
of 7. After the incubation period the electrode was washed with the PBS buffer
containing 0.05% Tween-20. This electrode was then incubated immediately with 20WL
of 2% BSA + 0.05% Tween-20 again followed by washing with PBS buffer and 0.05%
Tween-20.

The SWNT-Ab1 electrode was then incubated at 37°C for 1hr and 15minutes with 10WL
of PSA-antigen at varying concentrations. This step was again followed by washing with
PBS buffer containing 0.05% Tween-20. The SWNT-Ab1-PSA electrode was then
incubated for 1 hr. 15min. at 37°C with 10WL of 4pmol/mL HRP-labeled anti-PSA
antibody (Ab2-HRP). Again the electrode was washed after incubation with PBS buffer
containing 0.05% Tween-20. All washing steps were vital as they prevent non-specific
binding (NSB), which would result in a false-positive amperometric detection of PSA
antigen.

This working electrode containing the sandwich immunoassay was then placed in a 3electrode cell for cyclic voltammetry and amperometry at room temperature. The cell
contained 10mL of PBS buffer at pH 7 and 1mM of hydroquinone. Electrochemical
signals were generated with the use of the CHI 660C electrochemical workstation. Cyclic
voltammetry scans were run on each electrode to prep it for electron exchange in the
amperometric detection. This provided information on the redox ability of the electrode
prior to amperommetry. Amperometric detection was then run at -0.3V with the working
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electrode rotated at 3000rpm. Micromolar injections of 0.4mM H2O2 were used to
generate the stepwise signal.

3.4.

Results and Discussion

Prostate specific antigen (PSA) is a biomarker for prostate carcinoma, and is an
established clinical tool for diagnosing and monitoring the disease.30 We first analyzed
undiluted calf serum containing different amounts of PSA with the SWNT
immunosensors with anti-PSA attached (Figure 3-2). Inhibition of nonspecific binding
(NSB) was critical to achieve the best sensitivity and detection limits. Thus, we
developed a highly effective blocking procedure utilizing competitive binding of bovine
serum albumin (BSA) and the detergent Tween-20, and also optimized the concentration
of tracer secondary anti-PSA antibody (Ab2-HRP) (see Experimental Section). Before
exposure to the sample, immunosensors were incubated for 1 h with 20 mL 2% BSA +
0.05% Tween-20, then washed with 0.05% Tween-20 in buffer. For measurements, 10
mL undiluted new born calf serum containing PSA was incubated on the inverted sensor
surface, blocking buffer was used to wash; then the sensor was incubated with 10 mL
HRP-labeled secondary anti-PSA. The washed immunosensor was then placed into an
electrochemical cell containing the mediator hydroquinone in buffer, and hydrogen
peroxide was injected for signal development (Figure 3-2).

The steady state current increased linearly (Figure 3-3) with PSA concentration over the
range 0.4-40 ng mL-1, encompassing the 4-10 ng mL-1 prostate cancer prediction range
for human serum. Excellent device-to-device reproducibility is illustrated by the small
error bars, and sensitivity of 9.88 nAmL ng -1 (Figure 3-3B) was achieved. The detection
31

limit of 0.4 ng mL-1 as the zero PSA control signal plus three-times the control noise level
(Figure 3-2 inset) was similar to that obtained for PSA in buffers (not shown). Results
indicate that using BSA and detergent for NSB blocking, and optimizing the
concentration of Ab2-HRP is very effective to minimize NSB in serum. Control
experiment, Figure 3-2 inset, represents a SWNT immunosensor taken through the full
procedure without exposure to PSA, and the response reflects the sum of residual NSB
and direct reduction of hydrogen peroxide. The controls with no PSA responses were
significantly smaller than full immunoassay with the lowest PSA concentration, 0.4
ngmL-1. Results described above with this non-amplified SWNT immunosensors show
that we can accurately detect cancer biomarkers in complex biological samples with very
good sensitivity and selectivity (Figures 3-2 and 3-3). Further, the immunosensors have a
very good reproducibility, as demonstrated by device-to-device standard deviations.

3.5.

Summary

In summary, we have demonstrated a sensitive and selective electrochemical detection of
a protein cancer biomarker with SWNT immunosensors, as exemplified by the
measurement of PSA in clinically relevant serum samples. The detection limit of 4 ng
mL-1 for this non-amplified SWNT immunosensor compares favorably with the standard
enzyme linked immunosorbent assay (ELISA). This SWNT immunosensors can be
adapted easily for the detection of other relevant biomarkers and have the potential for
fabrication into arrays to facilitate multiplexed detection. We believe that such devices
will evolve toward a very promising future for reliable point-of-care diagnostics of cancer
and other diseases, and as tools for intra-operation pathological testing, proteomics, and
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.

Figure 3-2A. Amperometric signal generation for SWNT immunosensors incubated with
varying concentrations of PSA antigen. Current levels at -0.3V vs. SCE and 3000rpm
rotation.
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Figure 3-2B. Amperometric signal generation for SWNT immunosensors at detection
limits. Current levels at -0.3V vs. SCE and 3000rpm rotation.
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Figure 3-3. Influence of PSA concentration on amperometric signal. Error bars indicate
standard deviation of values.
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systems biology. Work is in progress in our lab to lower the detection limits using signal
amplification strategies.

Chapter 4
The Pell Scholars Honors Program Connection
4.1

Connection

The Pell Honors program was created in conjunction with retired United States Senator
Claiborne DeBorda Pell and Salve Regina University. During Mr. Pell’s Senate career he
spent 34 years on the Foreign Relations Committee; always true to the founding
principles of the United Nations in his work. In honor of his life and work the Pell
Program was formed to create a network of students from different disciplines that would
focus a portion of their studies on international relations and public policy, placing an
emphasis on a sense of civic responsibility46. In light of this, my senior thesis focused on
the electrochemical detection of protein biomarkers, expressly prostate specific antigen,
for use in the identification of prostate cancer. This technology has the potential for a
wide range of applications. Hopefully, with these detection protocols the future costs of
disease treatment will be lowered as diagnoses of disease will occur much earlier.

With the exception of skin cancer, prostate cancer is the most commonly diagnosed
cancer in American men and second leading cause of cancer deaths. 20% of men will
develop prostate cancer that is invasive before death. Currently digital rectal exams

46

"The Pell Scholars Honors Program." The Pell Center for International Relations and Public Policy.
2007. Salve Regina University. 10 Mar. 2007<http://www.salve.edu/pellcenter/scholars.cfm#overview>.
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(DREs) in conjunction with tests for the protein serum marker Prostate Specific Antigen
(PSA) are the methods employed in diagnoses of this disease47.

The cost of treatment for such a devastating disease can be very high. The cost by
definition encompasses physician and healthcare professionals, care provided by
hospitals, drugs, and laboratory services48. Many studies have been conducted to
determine the cost-benefit of early cancer detection. Figure 4-1 and Figure 4-2 describe
the benefit-cost equation and its variables as determined by the Cancer Journal for
Clinicians.

The data provided by the Cancer Journal for Clinicians indicates at current a negative
benefit-cost of screening for individuals as the current cost of testing outweighs the
benefits mathematically. The current data of this study indicates that early detection
could be more economical through a more specific PSA assay49. A population that is
growing older also indicates a higher incidence of disease in the future50.

47

Ferrini, Rebecca, and Steven Woolf. "Screening for Prostate Cancer in American Men." American
College of Preventive Medicine. 10 Mar. 2007 <http://www.acpm.org/prostate.htm>.
48
Grover, Steven, Hanna Zowall, Louis Coupal, and Murray Krahn. CMAJ: Canadian Medical Association
Journal, 1999, 160.
49
Littrup, P.J.; Goodman, A.C.; Mettlin, C.J.; CA: Cancer J Clin, 1993, 43, 134-149.
50
Norlund, A.; Alvegard, T.; Lithman, T.; Merlo, J.; Noreen, D.; Scand J Urol Nephrol, 2003, 37, 371-375.
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V=pnwB + (1-p)cR - S - [pn+ (1-p)(1-c)]w(T+A) - (1-p)(1-c)F
Dollar Values
V
B
R
S
T
A
F
Probabilities
p

Net benefit per individual screened
Value of benefits from early detection and treatment
Value of reassurance from a negative test
Cost of screening test, procedure, or scenario
Costs of staging and treatment received as a result of screening
Cost of adverse effects of screening tests and subsequent follow-up tests and morbidities
of therapy
Potential psychic cost of false-positive results

Prevalence of prostate cancer (fraction of patients who demonstrate cancer during
screening sequence, as well as from interval detection)

n
Sensitivity (probability of a positive results when clinically detectable cancer is present)
c

Specificity (probability of a negative result when no cancer is evident from the screening
test or sequence)

w

Probability of a patient returning for therapy and/or having a cancer stage or medical
condition appropriate for therapy

Figure 4-1. Benefit-cost equation of prostate cancer screening with definition of
variables49.
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Parameter Values for Benefit-Cost Analysis
DRE (highly skilled
examiner)
DRE (generalized)
DRE + PSA 2ng/mL
DRE + PSA 3ng/mL
DRE + PSA 4ng/mL
PSA 2ng/mL
PSA 3ng/mL
PSA 4ng/mL
Mammography

B

R

A

T

A

F

p

n

c

q

V

$29,443
$29,443
$29,443
$29,443
$29,443
$29,443
$29,443
$29,443
$29,443

$90
$90
$180
$180
$180
$90
$90
$90
$50

$90
$90
$180
$180
$180
$90
$90
$90
$50

$20,000
$20,000
$20,000
$20,000
$20,000
$20,000
$20,000
$20,000
$20,000

$1,391
$1,391
$1,470
$1,438
$1,421
$1,477
$1,436
$1,413
$1,450

$1,391
$1,391
$1,470
$1,438
$1,421
$1,477
$1,436
$1,413
$1,450

0.053
0.053
0.053
0.053
0.053
0.053
0.053
0.053
0.005

0.606
0.484
0.96
0.899
0.869
0.909
778
0.667
0.8

0.963
0.77
0.688
0.827
0.896
0.705
0.853
0.927
0.97

0.85
0.85
0.85
0.85
0.85
0.85
0.85
0.85
0.99

-$474
-$4,112
-$5,544
-$2,936
-$1,645
-$5,126
-$2,473
-$1,126
-$562

Figure 4-2. Benefit-cost equation of prostate cancer screening variable values49.
This indicates a need for a better method of PSA detection that would be available at a
lower cost which would make screening accessible to a larger portion of the population.
Our current research is looking to create an effective sensitive and cost effective method
for PSA analysis leading to earlier and more accurate detection. In the future, not only
will PSA be detected for but also multiple biomarkers proteins including PF4 and MMP2
that are currently under investigations in our lab.

As a result of this technology,

hopefully a dramatic decrease in prostate cancer deaths will occur.
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